Abstract
Galactomannan (GM) was recently included in consensus guidelines as an indirect mycological criterion for the diagnosis of invasive aspergillosis. Currently, there is an enzyme immunoassay available to detect GM in biological samples, the Platelia™ Aspergillus EIA. In this study, the reproducibility of positive results obtained using this assay was evaluated using serum samples from neutropenic patients. A trend toward lower values was observed, and 55 %(27/49) of positive results were negative after retesting. A low reproducibility of positive results for the detection of GM in serum was observed.
This is a preview of subscription content, log in via an institution to check access.
References
Racil Z, Kocmanova I, Toskova M, Buresova L, Weinbergerova B, Lengerova M, et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. IJDI. 2011;15:874–81.
Hadrich I, Makni F, Cheikhrouhou F, Neji S, Amouri I, Sellami H, Trabelsi H, Bellaaj H, Elloumi M, Ayadi A. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis. Pathol Biol. 2012;60(6):357–61.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–21.
ANVISA. Resolução nº3.288, de 19 de outubro de 2007. Available at http://www.anvisa.gov.br/legis/suplemento/221007_suplemento_1.pdf. Accessed on 12-Oct-2012.
Aquino VR, Goldani EZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007;163:191–202.
Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. JAC. 2008;61:411–6.
Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. CID. 2007;44:1329–33.
Bizzini A, Marchetti O, Meylan P. Response to: lack of intra-laboratory reproducibility in using platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen. Transpl Infect Dis. 2012;14:218–9.
Oren I, Avidor I, Sprecher H. Lack of intra-laboratory reproducibility in using platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen. Transpl Infect Dis. 2012;14:107–9.
Furfaro E, Mikulska M, Miletich F, Viscoli C. Galactomannan: testing the same sample twice? Transpl Infect Dis. 2012;14:38–9.
Nucci M, Nouer SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E. Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. CID. 2010;51:1273–80.
Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis. 2004;4(6):349–57.
Acknowledgments
FAPESB, Fundação de Amparo à Pesquisa do Estado da Bahia; CAPES, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; ISID/Federal University of Bahia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pedroza, K.C.M.C., de Matos, S.B., de Moura, D.L. et al. Reproducibility of Positive Results for the Detection of Serum Galactomannan by Platelia™ Aspergillus EIA. Mycopathologia 176, 295–297 (2013). https://doi.org/10.1007/s11046-013-9670-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-013-9670-z